UM Gallery

University is a place where researchers have the freedom to discover new knowledge and to innovate. Hence, in line with this, academicians and researchers are the pillar of strength of our foundation in the University of Malaya (UM).

Introduction:
For decades, Qigong, a Chinese form of exercise, has been widely acknowledged by many Asian cancer survivors as a potent health-promoting physical activity. However, there is a lack of evidence on its effectiveness. In addition, lifestyle factors including physical activity participation is now a recommended guideline in cancer survivors care plan, to optimize potential benefits in reducing cancer recurrence and mortality.

Thus, the aim of this RCT is to investigate the hypothesis that QoL in the Qigong group is better than the placebo (aerobic) or usual care group

The Null Hypothesis: there is no difference in the QOL (measured with Fact G) amongst women who participate in the 8 weeks QiGong compared to the placebo or control group.

Research Plan: Design:
A prospective randomized controlled (3-armed), single blind study was conducted from March 2010-June 2011 at University Malaya Medical Centre (UMMC). The intervention period was over eight weeks, with measurement taken at baseline and post-intervention.

Subject:
197 participants were randomly assigned to Qigong, Placebo or Usual care (control) group.Inclusion criteria were: a) aged between 18 to 65 years; b) be first time diagnosis of breast cancer; c) be diagnosed with early stage breast cancer (stage I-II); d) had completed primary treatment with no metastasis; e) at least one year post diagnosis.Exclusion Criteria were: a) having medical contraindications for exercise b) having major medical condition like epilepsy, uncontrolled hypertension, or cardiovascular diseases; c) currently (already) engaging in Qigong or structured aerobic exercises; and d) engaging in more than four hours in vigorous physical activities (score high in International Physical Activity Questionnaire, IPAQ). Sample size was calculated based on an earlier study done by Saxton [17] whereby, to obtain a between-group mean-difference of 10 units SD (standard deviation) on the FACT-G score, at least 38 participants in each group were required for 80% power and at p< 0.05.

Outcome measures:
The primary outcome is QoL as measured with FACT G FACT-G is a 27-item self-report instrument designed to measure multidimensional QoL in patients with cancer. FACT-G documented a high internal coefficient (α = 0.89) for total score and its subscale alpha coefficients ranging from 0.69- 0.82. [19] The alpha coefficient (internal consistency) for the FACT-B total score was high (α =0.90) as well. [20]